Showing 1 - 3 results of 3 for search 'Lan V. Pham', query time: 0.03s Refine Results
  1. 1
    The synergy of the XPO1 inhibitors combined with the BET inhibitor INCB057643 in high-grade B-cell lymphoma via downregulation of MYC expression

    The synergy of the XPO1 inhibitors combined with the BET inhibitor INCB057643 in high-grade B-cell lymphoma via downregulation of MYC expression by Manman Deng, Jinshui Tan, Ziying Fan, Lan V. Pham, Feng Zhu, Xiaosheng Fang, Haijun Zhao, Kenh Young, Bing Xu

    Published 2023-10-01
    Get full text
    Article
  2. 2
    CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 Rearrangements

    CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 Rearrangements by Delin Yuan, Delin Yuan, Genhong Li, Genhong Li, Lian Yu, Yuelong Jiang, Yuelong Jiang, Yuanfei Shi, Yuanfei Shi, Qiulin Chen, Qiulin Chen, Xiaomei Ma, Lan V. Pham, Ken H. Young, Manman Deng, Manman Deng, Zhihong Fang, Zhihong Fang, Bing Xu, Bing Xu

    Published 2021-03-01
    Get full text
    Article
  3. 3
    XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

    XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53 by Manman Deng, Mingzhi Zhang, Zijun Y. Xu-Monette, Lan V. Pham, Alexandar Tzankov, Carlo Visco, Xiaosheng Fang, Govind Bhagat, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, William W. L. Choi, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Fredrick Hagemeister, Lapo Alinari, Yong Li, Michael Andreeff, Bing Xu, Ken H. Young

    Published 2020-11-01
    Get full text
    Article

Search Tools: